Predictive gene signatures for bevacizumab and cetuximab as well as cytotoxic agents.
©2012 Dustri-Verlag Dr. K. Feistle ISSN 0946-1965 DOI 10.5414/CPP50070 e-pub: December 28, 2011 Correspondence to Prof. Dr. Heinz-Herbert Fiebig Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12 – 14, 79108 Freiburg, Germany Fiebig@Oncotest.de